Specialty chocolate bars are being removed from store shelves after concerns were raised about possible salmonella contamination, the US Food and Drug Administration said on January 12. Spring & Mulberry has announced a voluntary recall of its Mint Leaf Date-Sweetened Chocolate Bar, which has been sold online and at selected retail locations across the country since September, the FDA confirmed.

The issue was flagged during routine testing carried out by an independent laboratory. So far, no illnesses or negative health effects linked to the product have been reported.

As per The Independent, consumers who purchased the recalled chocolate are being advised to throw it away and seek a refund from Spring & Mulberry. The company has asked customers to contact them directly and provide a photograph of the chocolate bar showing the affected lot code.

Chocolate Bars Sold Across The US Recalled Over Salmonella Concerns

A well-known chocolate brand has issued a recall after possible salmonella contamination was detected. Spring & Mulberry, a Raleigh, North Carolina-based company, voluntarily recalled its Mint Leaf Date-Sweetened Chocolate Bar following routine third-party testing that found traces of salmonella, according to an FDA notice released Monday.

The recalled bars have been sold online and through selected retail partners since September 15, 2025. Consumers can identify the affected product by its teal-colored packaging and the lot code 025255 printed on the back of the box and the inner wrapper.

What Is Salmonella?

• Bloody diarrhea or diarrhea that lasts more than three days without improvement
• Diarrhea accompanied by a fever above 102 degrees
• Severe vomiting that makes it difficult to keep fluids down
• Signs of dehydration such as dry mouth, reduced urination, and dizziness when standing
• Abdominal cramps

Symptoms usually appear between six hours and six days after exposure. While most people recover within four to seven days, those at higher risk, including children under 5 and adults over 65, may develop more severe illness that requires medical care or hospitalization.

Affected Lot Code For Recalled Chocolates

The recalled Spring & Mulberry chocolate carries the lot code #025255. This code applies specifically to the Mint Leaf Date-Sweetened Chocolate Bar that has been pulled from the market due to the potential risk of salmonella contamination identified during routine lab testing.

Shoppers are urged to check their packaging carefully for the listed lot code. Anyone who has a bar with the affected code should not eat it. Instead, they should discard the product and contact Spring & Mulberry to request a refund.

As per USA TODAY, although no illnesses have been reported so far, the recall has been issued as a precaution to safeguard public health, especially for vulnerable groups such as children, older adults, and people with compromised immune systems. The FDA has shared further guidance on recall steps and salmonella symptoms.

The chocolate recall follows another FDA action just months earlier involving Doughy Chocolate Chip Cookie Dough produced by Hudson River Foods in November, also due to possible salmonella contamination. That recall was later upgraded to a Class I recall on December 5 after officials determined that consuming the product could result in serious health effects or death.

A total of 113 units of the edible cookie dough were included in that recall. The affected products were sold in 12-ounce containers and carried a best-by date of July 4, 2026.

On March 9, the United States issues a travel advisory against global polio and listed 32 countries, including some European countries. The International travel often comes with vaccine reminder and health checks to stay safe. The Centers for Disease Control and Prevention (CDC) issued a Level 2 travel advisory for certain international destinations with circulating poliovirus. The CDC has asked travelers to ensure they are up to date on their polio vaccines.

Also Read: Harish Rana Case Brings Spotlight On How Passive Euthanasia Has Evolved Over The Years

The Destination list for global polio travel Advisory notice includes:

• Afghanistan
• Algeria
• Angola
• Benin
• Burkina Faso
• Cameroon
• Central African Republic
• Chad
• Côte d'Ivoire
• Democratic Republic of the Congo
• Djibouti
• Ethiopia
• Gaza
• Germany
• Guinea
• Israel
• Laos
• Namibia
• Niger
• Nigeria
• Pakistan
• Papua New Guinea
• Poland
• Senegal
• Somalia
• South Sudan
• Sudan
• Tanzania
• United Kingdom
• Yemen

The CDC issued a 'Level 2' advisory, which means to 'practice enhanced precautions'.

The advisory suggests that children and adults should be up to date on their routine polio vaccines. Travelers are also asked to get an inactivated polio vaccine booster if they are going to the destination that has circulating poliovirus, or have completed their routine polio vaccine series; and have not already received one adult booster dose.

Also Read: Colon Cancer Is The Leading Cause Of Death In US For People Under 50

If Polio Has Been Eliminated In The US, Then Why Do Travelers Need Advisory?

Dr Leana Wen, CNN wellness expert, who is an emergency physician and adjunct associate professor at the George Washington University said that while the US eliminated continuous transmission of polio in 1979, eradication within the country does not eliminate the risk when people travel to places where the virus is still circulating.

Speaking to CNN, Wen said that the risk for any individual traveler is usually low if they are fully vaccinated, however, from a population health perspective, it is important to take the precautionary steps. "Even a single imported case could lead to local spread in communities where vaccination coverage is low."

Types Of Notices Issued By CDC

The CDC issues four different types of notices based on the gravity of the disease spread.

Level 1 : Practice Usual Precautions

Practice usual precautions for this destination, as described in the Travel Health Notice and/or on the destination page.

Level 2: Practice Enhanced Precautions

Practice enhanced precautions for this destination. The Travel Health Notice describes additional precautions or defines a specific population at risk.

Level 3: Reconsider Nonessential Travel

Reconsider nonessential travel to this destination. The outbreak or event poses risk to travelers because limited precautions are available.

Level 4: Avoid All Travel

Avoid travel to this destination unless traveling for humanitarian aid or emergency response; there is an extreme health risk for travelers and no available precautions.

What Is Polio?

The World Health Organization (WHO) notes that it is a highly infectious disease caused by a virus that invades the nervous system and can cause total paralysis in matter of hours. The virus is transmitted by person to person spread mainly through the fecal-oral route, or less frequently, by a common vehicle, which could be either from contaminated food or water. The virus also multiplies in the intestine.

The National Institute of Health (NIH), US, notes that the virus responsible for causing Polio belongs to the Picornaviridae family.

As per the WHO, the common Polio symptoms are:

• Fever
• Fatigue
• Headache
• Vomiting
• Stiffness of the neck a
• Pain in the limbs

How Does Polio Spread?

Polio is mainly transmitted through the fecal-oral route, meaning it spreads when a person consumes food or water contaminated with the virus. It can also spread through close contact with an infected individual. The poliovirus lives in the throat and intestines of those infected, and poor sanitation, unsafe water, and inadequate hygiene greatly increase the risk of transmission, especially in communities with limited access to clean facilities.

In severe cases, polio can lead to acute flaccid paralysis, which may affect the diaphragm and throat muscles, making it difficult to breathe or swallow. Since there is no cure for polio, prevention remains the only line of defense. Raising awareness about polio vaccination is therefore essential to protect individuals, especially children, from this potentially life-threatening disease.

The ongoing conflict in the Middle East, which has stretched to more than 10 days, is disrupting health services and fueling the risk of several infectious diseases as well as environmental hazards, the World Health Organization (WHO) has said.

Citing national health authorities, the WHO reported casualties:

• Iran - over 1,300 died, 9,000 injured
• Lebanon - 570 people died and more than 1,400 injured
• Israel - 15 died and 2,142 injured.

These include:

• Iran

- 8 deaths among health workers

• Lebanon

- 16 deaths and 29 injuries to health care workers.

"The conflict is affecting the very services meant to save lives," the WHO said.

"These attacks not only cost lives but deprive communities of care when they need it most. Health workers, patients, and health facilities must always be protected under international humanitarian law,” it added.

Notably, the conflict is also collapsing health system with the shutdown of critical medical services:

• Lebanon - 49 primary health care centers and 5 hospitals shut down.
• Occupied Palestinian territory - ambulances and mobile clinics access delayed.
• Gaza - medical evacuations suspended since 28 February
• WHO’s global logistics hub in Dubai - disruption in movement of medical supplies

Francesca Quinto, Desk Manager at Doctors Without Borders, in an update social media platform X informed the threat to healthcare facilities in Lebanon.

"Our teams are witnessing the suffering up close: hospitals under pressure, communities repeatedly displaced and humanitarian needs rising sharply. Civilians and healthcare facilities must be protected and access to care and safety must be guaranteed," Quinto said.

The global health body also flagged wider public health risks due to the crisis, driving up disease risks among people displaced and living in shelter camps with limited access to safe water, sanitation, and hygiene.

As per current estimates, more than 100,000 people in Iran have relocated to other areas of the country due to insecurity, and up to 700,000 people have been internally displaced in Lebanon.

"These conditions increase the risk of respiratory infections, diarrheal diseases, and other communicable illnesses, especially for the most vulnerable populations, such as women and children," the WHO said.

Black Rain And Environmental Hazard

In addition, the Middle East crisis is also increasing concerns over environmental hazards. The petroleum fires and smoke from damaged infrastructure in Iran are potentially causing breathing problems, eye and skin irritation, and contaminated water and food sources.

Recently, Iran saw black rainfall after overnight Israeli strikes on several fuel depots caused fires to burn for hours.

Iran's Red Crescent Society had warned the residents of Tehran and the surrounding region that the rainfall after the strikes could be "highly dangerous and acidic", and could cause "chemical burns of the skin and serious damage to the lungs".

Call For De-escalation

The WHO called on all countries to de-escalate the conflict and "to protect civilians and health care, ensure unimpeded and sustained humanitarian access".

The WHO Director General, Tedros Adhanom Ghebreyesus, shared concerns about the rising global military expenditure and the rising world hunger rates.

"Global military expenditure just hit $2.7 trillion - in a single year. According to the UN estimates, ending world hunger by 2030 would require $93 billion annually. That means we spend almost 30 times more every year on killing each other than on making sure everyone eats. Numbers don't lie. Our priorities do," he said, in a post on social media platform X.

About 30 to 83.7 million adults in the United States have Obstructive Sleep Apnea (OSA), notes American Lung Association. Roughly 80 per cent of these cases remain undiagnosed. However, now, a simple daily pill, an old drug, could just be the solution.

Scientists in Sweden and other places too, have been studying the anti-seizure medicine sultiame as a treatment for OSA. In their latest Phase II trial, the scientists found that people on sultiame experienced an improvement in their apsea symptoms, and their sleep quality too improved as compared to those taking placebo.

The results points towards the potential of sultiame becoming an effective option for people with sleep apnea, especially those who cannot tolerate continuous positive airway pressure (CPACP) machines. The findings are published in The Lancet, and the researchers noted: "These findings offer perspective for a pharmaceutical approach to treatment of patients with obstructive sleep apnea."

Sleep Apnea Pill: What Is This Condition?

OSA is the most common form of sleep apnea, and it happens when airway muscles physically block a person's breathing during sleep. This could pause the body to wake up enough to start breathing again, only for the cycle to restart throughout the night, anywhere from five to 100 times an hour. This also causes low oxygen levels and disturb people's sleep and, over time, can raise the risk of other long-term health problems, which could include heart diseases and even dementia.

What CPAP machines do is they use air pressure to keep the airways open during sleep. While machines are an effective way, some people have trouble using them long term, which is why some companies use less cumbersome interventions, including medicines.

Read: Harish Rana Case Highlights Why Planning For A Living Will Is Important

Sleep Apnea Pill: What Was It Used For?

Sultimae or sulthiame was first launched in the 1960s by Bayger AG as an anticonvulsant - which means, it was a drug designed to treat epilepsy and prevent seizures by stabilizing nerve cell membranes and reducing abnormal, excessive electrical activity in the brain.

What the drug does is, it inhibits carbonic anhydrase, an enzyme that plays a role in regulating our breathing. Research also suggested that this could help people with sleep apnea by preventing airway collapse. The US-based Apnimed, in collaboration with the Japenese company Shionogi & Co., Ltd., have been looking to develop sultiame as a sleep apnea treatment.

How Well Has The Sleep Apnea Pill Been Tested?

The phase II of the trial involved 298 patients. Of them were untreated, moderate and people with severe sleep apnea. The people were observed for over a 15-week period, of them, half were randomized to a placebo pill to be taken right before bed, while rest were given varying doses of sultiame.

The results showed that people who took sultiame saw a noticeable decrease in apnea symptoms and also witnessed improvements in their sleep quality and daytime sleepiness. People in the highest dose group saw the most improvement, with apnea symptoms being reduced up to 47 per cent.

“It feels like a breakthrough, and we now look forward to larger and longer studies to determine whether the effect is sustained over time and whether the treatment is safe for broader patient groups,” said study researcher Jan Hedner, a senior professor of pulmonary medicine at the University of Gothenburg.